University of Hertfordshire

Polymeric gels for intravaginal drug delivery

Research output: Contribution to journalArticle

Documents

View graph of relations
Original languageEnglish
Number of pages13
Pages (from-to)145-157
JournalJournal of Controlled Release
Journal publication date28 Jan 2018
Volume270
Early online date6 Dec 2017
DOIs
Publication statusPublished - 28 Jan 2018

Abstract

Intravaginal drug delivery can elicit a local effect, or deliver drugs systemically without hepatic first pass metabolism. There are a number of emerging areas in intravaginal drug delivery, but the vagina is a challenging route of administration, due to the clearance mechanisms present which result in poor retention of dosage forms, and the potential for irritation and other adverse reactions. Gel formulations are desirable due to the ease of application, spreading and that they cause little to no discomfort to the patient. However, these dosage forms, in particular, are poorly retained and traditional gels typically have little control over drug release rates. This has led to a large number of studies on improving the retention of vaginal gels and modulating the controlled release of drugs from the gel matrix.

This review outlines the anatomy and physiology of the vagina, focussing on areas relevant to drug delivery. Medical applications of vaginally administered medicines is then discussed, followed by an overview of polymeric gels in intravaginal drug delivery. The sensorial properties of intravaginal gels, and how these relate to user compliance are also summarised. Finally, some important barriers to marketing approval are described.

Notes

This document is the Accepted Manuscript version of the following article: Michael T. Cook, and Marc b. Brown, ‘Polymeric gels for intravaginal drug delivery’, Journal of Controlled Release, Vol. 270: 145-157, January 2018. Under embargo until 6 December 2018. The final, definitive version is available online at DOI: https://doi.org/10.1016/j.jconrel.2017.12.004

ID: 12924171